We found that TIMP1, ITGA5, FCGR2B, UPP1, ISG20, TSPAN4, and LOXL1 are potential biomarkers correlated with the immune infiltration events in patients with glioblastoma (Fig. 3 and Table 1). This evidence concerns the gene LOXL1 and glioblastoma.